A Dual-Mode Wireless Microsystem for Monitoring Dopamine and Spike Changes with Dexmedetomidine
Peiyao Jiao1,2, Yilin Song1,2, Jin Shan1,2
1State Key Laboratory of Transducer Technology, Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100190, China.
Cyborg and Bionic Systems (Washington, D.C.)
|May 25, 2026
Summary
Researchers developed a wireless microsystem for simultaneous electrophysiology and dopamine recording. This tool reveals how drugs like dexmedetomidine alter brain activity and dopamine release in vivo.
Area of Science:
- Neuroscience
- Biomedical Engineering
- Electrophysiology
Background:
- Existing methods for in vivo neural recording are often limited to single modalities (electrophysiology or electrochemistry) or use tethered systems.
- Tethered systems restrict animal movement, hindering the study of coordinated neural processes and pharmacological effects.
- There is a need for advanced tools capable of simultaneously capturing electrophysiological and electrochemical signals wirelessly.
Purpose of the Study:
- To develop and validate a dual-mode wireless microsystem for simultaneous recording of neural spikes, local field potentials (LFPs), and dopamine (DA)-related electrochemical signals.
- To assess the platform's performance in detecting dopamine and transmitting dual-mode signals wirelessly.
- To investigate the effects of dexmedetomidine on cortical electrophysiology and dopamine levels in vivo.
Main Methods:
- Development of a wireless microsystem integrating a modified electrochemical sensor for DA detection and independent electrophysiological and electrochemical acquisition pathways.
- In vitro validation of dopamine detection sensitivity, selectivity, and wireless transmission stability.
- In vivo recordings of simultaneous electrophysiological (spikes, LFPs) and electrochemical (DA) signals from the prelimbic cortex of rodents administered varying doses of dexmedetomidine.
Main Results:
- The wireless microsystem demonstrated stable in vitro dopamine detection and reliable wireless signal transmission.
- In vivo experiments showed that dexmedetomidine administration dose-dependently reduced spike firing rate and high-frequency LFP power.
- Simultaneously, dexmedetomidine caused dose-dependent increases in the DA-related amperometric response, indicating altered dopamine signaling.
Conclusions:
- The developed dual-mode wireless microsystem enables simultaneous, long-term monitoring of electrophysiological activity and neurochemical changes (dopamine) in freely moving animals.
- This technology provides a powerful new tool for understanding how pharmacological agents modulate complex neural circuits and neurotransmitter systems in vivo.
- The findings highlight the utility of integrated electrophysiological and electrochemical recordings for studying drug effects on brain function.


